Foresite Capital Management V as of March 31, 2021
Portfolio Holdings for Foresite Capital Management V
Foresite Capital Management V holds 20 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cullinan Oncology (CGEM) | 33.5 | $114M | 2.7M | 41.67 | |
| Gemini Therapeutics | 9.7 | $33M | 2.4M | 13.55 | |
| Aclaris Therapeutics (ACRS) | 9.3 | $32M | 1.3M | 25.20 | |
| Kinnate Biopharma (KNTE) | 8.0 | $27M | 875k | 31.16 | |
| Alx Oncology Hldgs (ALXO) | 6.9 | $24M | 320k | 73.74 | |
| Pharvaris N V (PHVS) | 5.5 | $19M | 664k | 27.98 | |
| Nurix Therapeutics (NRIX) | 4.1 | $14M | 452k | 31.09 | |
| Hims & Hers Health Com Cl A (HIMS) | 4.1 | $14M | 1.1M | 13.23 | |
| Relay Therapeutics (RLAY) | 4.1 | $14M | 400k | 34.57 | |
| Population Health Investment Unit | 2.8 | $9.6M | 960k | 10.05 | |
| Olink Holding AB Sponsored Ads (OLK) | 2.1 | $7.2M | 200k | 36.00 | |
| FS Development Corp. II Com Cl A | 1.8 | $6.0M | 603k | 9.96 | |
| Lucira Health | 1.7 | $5.9M | 485k | 12.10 | |
| Research Alliance Corp. II Com Cl A | 1.5 | $5.1M | 500k | 10.25 | |
| Bctg Acquisition Corp | 1.3 | $4.4M | 400k | 11.12 | |
| Lifesci Acquisition Ii Corp | 1.2 | $4.1M | 400k | 10.14 | |
| Therapeutics Acquisition Corp Com Cl A | 1.1 | $3.7M | 350k | 10.51 | |
| Helix Acquisition Corp. Com Cl A | 0.7 | $2.6M | 250k | 10.20 | |
| Consonance-HFW Acquisition Corp. Unit | 0.3 | $976k | 100k | 9.76 | |
| Immunovant (IMVT) | 0.2 | $802k | 50k | 16.04 |
